Temporal relationships between systemic lupus erythematosus and comorbidities

医学 共病 危险系数 内科学 优势比 入射(几何) 置信区间 光学 物理
作者
Chang‐Fu Kuo,I‐Jun Chou,Frances Rees,Matthew J. Grainge,Peter Lanyon,Graham Davenport,Christian Mallen,Ting‐Ting Chung,Jung‐Sheng Chen,Weiya Zhang,Michael Doherty
出处
期刊:Rheumatology [Oxford University Press]
卷期号:58 (5): 840-848 被引量:53
标识
DOI:10.1093/rheumatology/key335
摘要

Abstract Objective To examine the burden of comorbidities prior to and after the diagnosis of SLE and its impact on mortality. Methods We identified 1605 incident cases of SLE and 6284 matched controls from the UK primary care. The risks of comorbidities before (prevalence; odds ratios) and after SLE diagnosis (incidence; hazard ratios) and the impact of comorbidities at diagnosis on all-cause mortality were estimated. Results At diagnosis, SLE was associated with adjusted odds ratios (95% CI) of 2.25 (1.97–2.56), 3.37 (2.49–4.57) and 3.54 (1.89–6.63) for a Charlson comorbidity index of 1–2, 3–4 and ≥5, respectively. Following diagnosis, SLE also associated with increased risk of developing any comorbidity with an adjusted hazard ratio (95% CI) of 1.30 (95% CI, 1.13–1.49). At diagnosis, SLE was associated with a greater risk of cancer, cardiovascular, renal, liver, rheumatological and neurological diseases as well as depression, anaemia and psoriasis. Risks of developing incident comorbidity in the categories of neoplasm, cardiovascular, genitourinary, metabolic/endocrine, gastrointestinal and hepatic diseases, chronic pulmonary diseases, musculoskeletal/connective tissue and neurological diseases were higher in SLE patients. People with SLE had higher mortality risk compared with controls, with adjusted hazard ratio of 1.91 (95% CI, 1.62–2.26); after further adjusting for comorbidities this reduced to 1.64 (1.37–1.97). Comorbidities at SLE diagnosis accounted for 27.6% of the apparent difference in mortality between SLE patients and matched controls. Conclusion People with SLE have increased risks of multiple comorbidities both prior to and after diagnosis and this contributes significantly to all-cause mortality.

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
月月发布了新的文献求助10
1秒前
小黄同学完成签到,获得积分10
1秒前
CG2021发布了新的文献求助10
1秒前
2秒前
汉堡包应助CX采纳,获得10
2秒前
2秒前
屁王发布了新的文献求助10
2秒前
Sawyar完成签到,获得积分10
3秒前
3秒前
李健的小迷弟应助许诺诺采纳,获得10
4秒前
huihui2121完成签到,获得积分10
4秒前
ww发布了新的文献求助10
4秒前
5秒前
6秒前
Smanz发布了新的文献求助20
6秒前
6秒前
QinQin发布了新的文献求助10
7秒前
科研通AI2S应助hh0采纳,获得10
7秒前
莫之白完成签到,获得积分10
7秒前
苗条豆芽发布了新的文献求助10
8秒前
Zion完成签到,获得积分0
8秒前
8秒前
糟糕的学姐完成签到,获得积分10
8秒前
轻语完成签到 ,获得积分10
9秒前
脑洞疼应助xxxx采纳,获得10
10秒前
fan完成签到,获得积分10
10秒前
YY发布了新的文献求助10
11秒前
cannon8发布了新的文献求助200
11秒前
12秒前
LL完成签到,获得积分10
12秒前
zzw发布了新的文献求助10
12秒前
月月发布了新的文献求助10
13秒前
ran发布了新的文献求助10
13秒前
隐形的巴豆完成签到,获得积分10
15秒前
15秒前
16秒前
li完成签到 ,获得积分20
16秒前
彭于彦祖应助科研通管家采纳,获得30
16秒前
不配.应助科研通管家采纳,获得20
17秒前
脑洞疼应助金华采纳,获得10
17秒前
高分求助中
The late Devonian Standard Conodont Zonation 2000
The Lali Section: An Excellent Reference Section for Upper - Devonian in South China 1500
Nickel superalloy market size, share, growth, trends, and forecast 2023-2030 1000
Smart but Scattered: The Revolutionary Executive Skills Approach to Helping Kids Reach Their Potential (第二版) 1000
Mantiden: Faszinierende Lauerjäger Faszinierende Lauerjäger 800
PraxisRatgeber: Mantiden: Faszinierende Lauerjäger 800
A new species of Coccus (Homoptera: Coccoidea) from Malawi 500
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 基因 遗传学 催化作用 物理化学 免疫学 量子力学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 3245464
求助须知:如何正确求助?哪些是违规求助? 2889085
关于积分的说明 8256869
捐赠科研通 2557437
什么是DOI,文献DOI怎么找? 1386114
科研通“疑难数据库(出版商)”最低求助积分说明 650285
邀请新用户注册赠送积分活动 626541